Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
4.640
+0.130 (2.88%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cogent Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
529862506808342350
Upgrade
Market Cap Growth
70.14%70.14%-37.32%136.30%-2.42%-
Upgrade
Enterprise Value
259644273605228365
Upgrade
Last Close Price
4.647.805.8811.568.5811.23
Upgrade
PS Ratio
-----44.52
Upgrade
PB Ratio
3.523.361.963.161.601.49
Upgrade
P/TBV Ratio
3.635.912.564.262.662.83
Upgrade
EV/Sales Ratio
-----46.36
Upgrade
Debt / Equity Ratio
0.070.070.070.080.020.02
Upgrade
Asset Turnover
-----0.05
Upgrade
Quick Ratio
5.155.156.969.6612.8618.50
Upgrade
Current Ratio
5.325.327.099.8713.0418.70
Upgrade
Return on Equity (ROE)
-99.54%-99.54%-74.94%-59.69%-32.20%-56.16%
Upgrade
Return on Assets (ROA)
-53.78%-53.78%-42.35%-34.68%-19.55%-14.69%
Upgrade
Return on Capital (ROIC)
-62.67%-62.67%-47.13%-37.51%-20.66%-15.89%
Upgrade
Earnings Yield
-48.40%-29.70%-38.00%-17.36%-21.14%-21.35%
Upgrade
FCF Yield
-39.41%-24.18%-30.89%-15.53%-17.69%-10.23%
Upgrade
Buyback Yield / Dilution
-30.36%-30.36%-35.54%-51.89%-249.52%-45.42%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q